Elite Pharmaceuticals, Inc. (ELTP) Capital expenditures 2017–2026
Elite Pharmaceuticals, Inc. (ELTP) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$925,626FY2026 · since FY2017: $1.1M → $925,626
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $925,626 | -43.0% |
| FY2025 | $1.6M | +100.7% |
| FY2024 | $809,653 | -85.9% |
| FY2023 | $5.7M | +1050.6% |
| FY2022 | $498,566 | +51.1% |
| FY2021 | $329,981 | +844.1% |
| FY2020 | $34,953 | +82.7% |
| FY2019 | $19,130 | -89.4% |
| FY2018 | $180,937 | -83.5% |
| FY2017 | $1.1M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice